ACETAZOLAMIDE (acetazolamide) by PharmaIN is carbonic anhydrase inhibitors [moa]. Approved for glaucoma. First approved in 2019.
Drug data last refreshed 20h ago
Carbonic Anhydrase Inhibitors
Carbonic Anhydrase Inhibitor
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men
HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men
HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men
Acetazolamide and Exercise Performance at Altitude
Worked on ACETAZOLAMIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.